Abstract
The combination of an ageing population and now recognised second peak of onset of IBD in individuals aged 60 and over means the management of IBD in the older person is becoming ever more important.
Comorbidity and polypharmacy are more likely in this age group which may impact upon management decisions, particularly in regard to the use of immunosuppressant, steroid and biological therapies.
This chapter considers specific considerations for nurses and other healthcare professionals managing the older person with IBD, highlighting appropriate assessment and management skills nurses can develop to play a meaningful role in the management of IBD in the elderly person.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Beard JR, Cassels AK (2016) The world report on ageing and health. Gerontologist 56:S268–S280
Charpentier C, Salleron J, Savoye G et al (2014) Natural history of elderly onset inflammatory bowel disease: A population-based cohort study. Gut 63:423–432
Cross RK, Wilson KT, Binion DG (2005) Polypharmacy and Crohn’s disease. Aliment Pharmacol Ther 21:1211–1216
Delaney CP, Dadvand B, Remzi FH, Church JM, Fazio VW (2002) Functional outcome, quality of life, and complications after ileal pouch-anal anastomosis in selected septuagenarians. Dis Colon Rectum 45:890–894
Gower-Rousseau C, Vasseur F, Fumery M, Savoye G, Salleron J, Dauchet L, Turck D, Cortot A, Peyrin-Biroulet L, Colombel JF (2013) Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD). Dig Liver Dis 45:89–94
Graham JE, Rockwood K, Beattie BL et al (1997) Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 349(9068):1793–1796
Jeuring SF, van den Heuvel TR, Zeegers MP et al (2016) Epidemiology and longterm outcome of inflammatory bowel disease diagnosed at elderly age – an increasing distinct entity? Inflamm Bowel Dis 22:1425–1434
Navaneethan U, Edminster T, Zhu X et al (2017) Vedolizumab is safe and effective in elderly patients with inflammatory bowel disease. Inflamm Bowel Dis 23:4 E17. https://doi.org/10.1097/MIB.00000000001071
Nguyen GC, Sheng L, Benchimol EI (2015) Health care utilization in elderly onset inflammatory bowel disease: A population-based study. Inflamm Bowel Dis 21:777–782
Nimmons D, Limdi JK (2016) Elderly patients and inflammatory bowel disease. World J Gastrointest Pharmacol Ther 7(1):51–65
Panara AJ et al (2014) The incidence and risk factors for developing depression after being diagnosed with IBD. Aliment Pharmacol Ther 39:802–810
Rao SS (2004) Diagnosis and management of fecal incontinence. Am J Gastroenterol 99:1585–1604
Siegel CA, Marden SM, Persing SM, Larson RJ, Sands BE (2009) Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn’s disease: A meta-analysis. Clin Gastroenterol Hepatol 7:874–881
Sturm A, Maaser C, Mendall M et al (2017) European Crohn’s and Colitis Organisation Topical reriew on IBD in the elderly. J Crohn’s Colitis 11(3):263–273
Velonias G, Conway G, Andrews E et al (2017) Older age and health related Quality of Life in inflammatory bowel disease. Inflamm Bowel Dis 23(2):283–288
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Younge, L., Ipenburg, N. (2019). Elderly. In: Sturm, A., White, L. (eds) Inflammatory Bowel Disease Nursing Manual. Springer, Cham. https://doi.org/10.1007/978-3-319-75022-4_27
Download citation
DOI: https://doi.org/10.1007/978-3-319-75022-4_27
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-75021-7
Online ISBN: 978-3-319-75022-4
eBook Packages: MedicineMedicine (R0)